世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000031899

世界の自家幹細胞および非幹細胞ベースの治療市場規模調査:タイプ別、製品別、用途別、エンドユーザー別、地域別の予測(2022年〜2028年)

Bizwit Research & Consulting LLP

Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size study, By Type (Autologous Stem Cells, Autologous Non-Stem Cells), By Product (Blood Pressure (BP) Monitoring Devices, Pulmonary Pressure Monitoring Devices, Intracranial Pressure (ICP) Monitoring Devices), By Application (Neurodegenerative Disorders, Autoimmune Diseases, Cancer and Tumors, Cardiovascular Diseases), By End-User (Hospitals, Ambulatory Surgical Center), and Regional Forecasts 2022-2028

発刊日 2022/03/02

言語英語

体裁PDF/200ページ

ライセンス/価格200ページ

0000031899

Single
Enterprisewide

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

自家幹細胞移植とは、個人の体内から幹細胞や同種細胞を取り出し、集積した後、同じ人に戻す移植の一形態です。幹細胞移植には、同種幹細胞移植と自家幹細胞移植の2種類があります。すべての年齢層における癌と糖尿病の有病率の増加、老年人口の増加、自家幹細胞および非幹細胞を主とした治療法に対する需要の増加、いくつかの有利な政府政策の実行が、市場の需要を加速させる主な要因となっています。たとえば、国立がん研究所によると、アメリカには約1,690万人の癌生存者がおり、2030年までに2,220万人に達すると予測されています。さらに、発展途上国における研究開発活動の数の増加と未開拓の広大な市場は 世界中の市場の成長をさらに推進します。しかし、熟練した専門家の不足が、2022年から2028年の予測期間における市場成長の妨げとなっています。また、再生医療における新しい自家幹細胞ベースの治療法の導入は、予測期間中の市場需要の触媒として作用すると予測されます。

自家幹細胞および非幹細胞ベースの治療の世界市場調査において考慮した主要地域には、アジア太平洋地域、北アメリカ、ヨーロッパ、ラテンアメリカ、その他の地域が含まれます。北アメリカは、多くの感染症治療のための医療インフラが整備されており、治療に伴うリスクを最小限に抑えられることから、市場シェアにおいて世界の主要地域となっています。一方、アジア太平洋地域は、2022年から2028年の予測期間において、最も高いCAGRを示すと予想されています。医療施設に対する投資の増加や、有利な償還政策の導入などの要因が、アジア太平洋地域における自家幹細胞および非幹細胞ベースの治療市場の有利な成長見通しを生み出しています。

主要企業

  • Antria (CRO)
  • Bioheart
  • Brainstorm Cell Therapeutics
  • Cytori
  • Dendreon Corporation
  • Fibrocell
  • Genesis Biopharma
  • Georgia Health Sciences University
  • Neostem
  • Opexa Therapeutics

この調査の目的は、近年のさまざまなセグメントおよび国々の市場規模を定義し、今後8年間の価値を予測することです。本レポートは、調査対象となる各地域・国における産業の質的・量的側面を取り込むように設計されています。さらに、市場の今後の成長を決定づける推進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合状況や製品内容の詳細な分析とともに、利害関係者が投資できるミクロ市場での機会についても報告します。

セグメント・サブセグメント

  • タイプ別
    ➣ 自家幹細胞
    ➣ 非幹細胞
  • 製品別
    ➣ 血圧測定装置
    ➣ 肺圧監視装置
    ➣ 頭蓋内圧(ICP)モニタリング装置
  • 用途別
    ➣ 神経変性疾患
    ➣ 自己免疫疾患
    ➣ 癌・腫瘍
    ➣ 心血管疾患
  • エンドユーザー別
    ➣ 病院
    ➣ 外来手術センター
  • 地域別
    ➣ 北アメリカ
      ◇ アメリカ
      ◇ カナダ
    ➣ ヨーロッパ
      ◇ イギリス
      ◇ ドイツ
      ◇ フランス
      ◇ スペイン
      ◇ イタリア
      ◇ その他のヨーロッパ
    ➣ アジア太平洋地域
      ◇ 中国
      ◇ インド
      ◇ 日本
      ◇ オーストラリア
      ◇ 韓国
      ◇ その他のAPAC
    ➣ ラテンアメリカ
      ◇ ブラジル
      ◇ メキシコ
    ➣ 世界のその他の地域

調査対象年

  • 実績データ - 2018年、2019年、2020年
  • 基準年 - 2021年
  • 予測期間 - 2022年から2028年

レポート詳細

目次

Table of Contents

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
1.2.1. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market, by Region, 2020-2028 (USD Billion)
1.2.2. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market, by Type, 2020-2028 (USD Billion)
1.2.3. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market, by Product, 2020-2028 (USD Billion)
1.2.4. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market, by Application, 2020-2028 (USD Billion)
1.2.5. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market, by End-User, 2020-2028 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption

Chapter 2. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates

Chapter 3. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Dynamics
3.1. Autologous Stem Cell and Non-Stem Cell Based Therapies Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Increasing prevalence of targeted diseases
3.1.1.2. Growing geriatric population
3.1.2. Market Challenges
3.1.2.1. Lack of skilled professionals
3.1.3. Market Opportunities
3.1.3.1. Introduction of novel autologous stem cell-based therapies in regenerative medicine

Chapter 4. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2019-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 market scenario

Chapter 6. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market, by Type
6.1. Market Snapshot
6.2. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market by Type, Performance - Potential Analysis
6.3. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Estimates & Forecasts by Type 2019-2028 (USD Billion)
6.4. Autologous Stem Cell and Non-Stem Cell Based Therapies Market, Sub Segment Analysis
6.4.1. Autologous Stem Cells
6.4.2. Autologous Non-Stem Cells

Chapter 7. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market, by Product
7.1. Market Snapshot
7.2. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market by Product, Performance - Potential Analysis
7.3. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Estimates & Forecasts by Product 2019-2028 (USD Billion)
7.4. Autologous Stem Cell and Non-Stem Cell Based Therapies Market, Sub Segment Analysis
7.4.1. Blood Pressure (BP) Monitoring Devices
7.4.2. Pulmonary Pressure Monitoring Devices
7.4.3. Intracranial Pressure (ICP) Monitoring Devices

Chapter 8. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market, by Application
8.1. Market Snapshot
8.2. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market by Application, Performance - Potential Analysis
8.3. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Estimates & Forecasts by Application 2019-2028 (USD Billion)
8.4. Autologous Stem Cell and Non-Stem Cell Based Therapies Market, Sub Segment Analysis
8.4.1. Neurodegenerative Disorders
8.4.2. Autoimmune Diseases
8.4.3. Cancer And Tumors
8.4.4. Cardiovascular Diseases

Chapter 9. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market, by End-User
9.1. Market Snapshot
9.2. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market by End-User, Performance - Potential Analysis
9.3. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Estimates & Forecasts by End-User 2019-2028 (USD Billion)
9.4. Autologous Stem Cell and Non-Stem Cell Based Therapies Market, Sub Segment Analysis
9.4.1. Hospitals
9.4.2. Ambulatory Surgical Center

Chapter 10. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market, Regional Analysis
10.1. Autologous Stem Cell and Non-Stem Cell Based Therapies Market, Regional Market Snapshot
10.2. North America Autologous Stem Cell and Non-Stem Cell Based Therapies Market
10.2.1. U.S. Autologous Stem Cell and Non-Stem Cell Based Therapies Market
10.2.1.1. Type estimates & forecasts, 2019-2028
10.2.1.2. Product estimates & forecasts, 2019-2028
10.2.1.3. Application estimates & forecasts, 2019-2028
10.2.1.4. End-User estimates & forecasts, 2019-2028
10.2.2. Canada Autologous Stem Cell and Non-Stem Cell Based Therapies Market
10.3. Europe Autologous Stem Cell and Non-Stem Cell Based Therapies Market Snapshot
10.3.1. U.K. Autologous Stem Cell and Non-Stem Cell Based Therapies Market
10.3.2. Germany Autologous Stem Cell and Non-Stem Cell Based Therapies Market
10.3.3. France Autologous Stem Cell and Non-Stem Cell Based Therapies Market
10.3.4. Spain Autologous Stem Cell and Non-Stem Cell Based Therapies Market
10.3.5. Italy Autologous Stem Cell and Non-Stem Cell Based Therapies Market
10.3.6. Rest of Europe Autologous Stem Cell and Non-Stem Cell Based Therapies Market
10.4. Asia-Pacific Autologous Stem Cell and Non-Stem Cell Based Therapies Market Snapshot
10.4.1. China Autologous Stem Cell and Non-Stem Cell Based Therapies Market
10.4.2. India Autologous Stem Cell and Non-Stem Cell Based Therapies Market
10.4.3. Japan Autologous Stem Cell and Non-Stem Cell Based Therapies Market
10.4.4. Australia Autologous Stem Cell and Non-Stem Cell Based Therapies Market
10.4.5. South Korea Autologous Stem Cell and Non-Stem Cell Based Therapies Market
10.4.6. Rest of Asia Pacific Autologous Stem Cell and Non-Stem Cell Based Therapies Market
10.5. Latin America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Snapshot
10.5.1. Brazil Autologous Stem Cell and Non-Stem Cell Based Therapies Market
10.5.2. Mexico Autologous Stem Cell and Non-Stem Cell Based Therapies Market
10.6. Rest of The World Autologous Stem Cell and Non-Stem Cell Based Therapies Market

Chapter 11. Competitive Intelligence
11.1. Top Market Strategies
11.2. Company Profiles
11.2.1. Antria (CRO)
11.2.1.1. Key Information
11.2.1.2. Overview
11.2.1.3. Financial (Subject to Data Availability)
11.2.1.4. Product Summary
11.2.1.5. Recent Developments
11.2.2. Bioheart
11.2.3. Brainstorm Cell Therapeutics
11.2.4. Cytori
11.2.5. Dendreon Corporation
11.2.6. Fibrocell
11.2.7. Genesis Biopharma
11.2.8. Georgia Health Sciences University
11.2.9. Neostem
11.2.10. Opexa Therapeutics

Chapter 12. Research Process
12.1. Research Process
12.1.1. Data Mining
12.1.2. Analysis
12.1.3. Market Estimation
12.1.4. Validation
12.1.5. Publishing
12.2. Research Attributes
12.3. Research Assumption

List of Tables
TABLE 1. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market, report scope
TABLE 2. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market estimates & forecasts by Region 2019-2028 (USD Billion)
TABLE 3. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market estimates & forecasts by Type 2019-2028 (USD Billion)
TABLE 4. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market estimates & forecasts by Product 2019-2028 (USD Billion)
TABLE 5. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market estimates & forecasts by Application 2019-2028 (USD Billion)
TABLE 6. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market estimates & forecasts by End-User 2019-2028 (USD Billion)
TABLE 7. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 8. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 9. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 10. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 11. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 12. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 13. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 14. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 15. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 16. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 17. U.S. Autologous Stem Cell and Non-Stem Cell Based Therapies Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 18. U.S. Autologous Stem Cell and Non-Stem Cell Based Therapies Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 19. U.S. Autologous Stem Cell and Non-Stem Cell Based Therapies Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 20. Canada Autologous Stem Cell and Non-Stem Cell Based Therapies Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 21. Canada Autologous Stem Cell and Non-Stem Cell Based Therapies Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 22. Canada Autologous Stem Cell and Non-Stem Cell Based Therapies Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 23. UK Autologous Stem Cell and Non-Stem Cell Based Therapies Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 24. UK Autologous Stem Cell and Non-Stem Cell Based Therapies Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 25. UK Autologous Stem Cell and Non-Stem Cell Based Therapies Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 26. Germany Autologous Stem Cell and Non-Stem Cell Based Therapies Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 27. Germany Autologous Stem Cell and Non-Stem Cell Based Therapies Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 28. Germany Autologous Stem Cell and Non-Stem Cell Based Therapies Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 29. RoE Autologous Stem Cell and Non-Stem Cell Based Therapies Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 30. RoE Autologous Stem Cell and Non-Stem Cell Based Therapies Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 31. RoE Autologous Stem Cell and Non-Stem Cell Based Therapies Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 32. China Autologous Stem Cell and Non-Stem Cell Based Therapies Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 33. China Autologous Stem Cell and Non-Stem Cell Based Therapies Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 34. China Autologous Stem Cell and Non-Stem Cell Based Therapies Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 35. India Autologous Stem Cell and Non-Stem Cell Based Therapies Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 36. India Autologous Stem Cell and Non-Stem Cell Based Therapies Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 37. India Autologous Stem Cell and Non-Stem Cell Based Therapies Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 38. Japan Autologous Stem Cell and Non-Stem Cell Based Therapies Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 39. Japan Autologous Stem Cell and Non-Stem Cell Based Therapies Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 40. Japan Autologous Stem Cell and Non-Stem Cell Based Therapies Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 41. RoAPAC Autologous Stem Cell and Non-Stem Cell Based Therapies Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 42. RoAPAC Autologous Stem Cell and Non-Stem Cell Based Therapies Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 43. RoAPAC Autologous Stem Cell and Non-Stem Cell Based Therapies Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 44. Brazil Autologous Stem Cell and Non-Stem Cell Based Therapies Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 45. Brazil Autologous Stem Cell and Non-Stem Cell Based Therapies Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 46. Brazil Autologous Stem Cell and Non-Stem Cell Based Therapies Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 47. Mexico Autologous Stem Cell and Non-Stem Cell Based Therapies Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 48. Mexico Autologous Stem Cell and Non-Stem Cell Based Therapies Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 49. Mexico Autologous Stem Cell and Non-Stem Cell Based Therapies Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 50. RoLA Autologous Stem Cell and Non-Stem Cell Based Therapies Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 51. RoLA Autologous Stem Cell and Non-Stem Cell Based Therapies Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 52. RoLA Autologous Stem Cell and Non-Stem Cell Based Therapies Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 53. Row Autologous Stem Cell and Non-Stem Cell Based Therapies Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 54. Row Autologous Stem Cell and Non-Stem Cell Based Therapies Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 55. Row Autologous Stem Cell and Non-Stem Cell Based Therapies Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 56. List of secondary sources, used in the study of global Autologous Stem Cell and Non-Stem Cell Based Therapies Market
TABLE 57. List of primary sources, used in the study of global Autologous Stem Cell and Non-Stem Cell Based Therapies Market
TABLE 58. Years considered for the study
TABLE 59. Exchange rates considered

List of figures
FIG 1. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market, research methodology
FIG 2. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market, market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market, key trends 2021
FIG 5. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market, growth prospects 2022-2028
FIG 6. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market, porters 5 force model
FIG 7. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market, pest analysis
FIG 8. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market, value chain analysis
FIG 9. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market by segment, 2019 & 2028 (USD Billion)
FIG 10. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market by segment, 2019 & 2028 (USD Billion)
FIG 11. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market by segment, 2019 & 2028 (USD Billion)
FIG 12. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market by segment, 2019 & 2028 (USD Billion)
FIG 13. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market by segment, 2019 & 2028 (USD Billion)
FIG 14. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market, regional snapshot 2019 & 2028
FIG 15. North America Autologous Stem Cell and Non-Stem Cell Based Therapies Market 2019 & 2028 (USD Billion)
FIG 16. Europe Autologous Stem Cell and Non-Stem Cell Based Therapies Market 2019 & 2028 (USD Billion)
FIG 17. Asia pacific market 2019 & 2028 (USD Billion)
FIG 18. Latin America Autologous Stem Cell and Non-Stem Cell Based Therapies Market 2019 & 2028 (USD Billion)
FIG 19. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market, company market share analysis (2021)

この商品のレポートナンバー

0000031899

TOP